Literature DB >> 34023000

Multilevel capillary gel electrophoresis characterization of new antibody modalities.

Csenge Filep1, Marton Szigeti2, Robert Farsang3, Markus Haberger4, Dietmar Reusch5, Andras Guttman6.   

Abstract

Capillary gel electrophoresis-based methods were applied to comprehensively characterize two development phase new modality monoclonal antibodies including a glycoengineered and a bispecific test compound. The samples were subjected to multilevel characterization at the intact (both by SDS-SGE and cIEF) as well as the reduced protein and the released N-glycan levels. SDS capillary gel electrophoresis analysis showed excellent separation of the light and heavy chains of both samples. The bispecific antibody required a special temperature gradient denaturation process and a longer capillary to resolve its two light chain fragments. Separation of PNGase F digested antibodies revealed migration time shifts, suggesting the presence of N-linked glycosylation on the corresponding subunits. For efficient glycan removal, the highly glycosylated glycoengineered monoclonal antibody was trypsin digested prior to the endoglycosidase treatment. The released glycans were profiled by capillary gel electrophoresis after APTS labeling and their oligosaccharide structures were identified by exoglycosidase based carbohydrate sequencing. Finally, capillary isoelectric focusing shed light on the charge heterogeneity of the test compounds, providing important complementary information. A flowchart was established for workflow optimization.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Monoclonal antibody; N-Glycan analysis; New modalities; SDS-CGE; Trypsin digestion

Year:  2021        PMID: 34023000     DOI: 10.1016/j.aca.2021.338492

Source DB:  PubMed          Journal:  Anal Chim Acta        ISSN: 0003-2670            Impact factor:   6.558


  2 in total

1.  Introduction of a Capillary Gel Electrophoresis-Based Workflow for Biotherapeutics Characterization: Size, Charge, and N-Glycosylation Variant Analysis of Bamlanivimab, an Anti-SARS-CoV-2 Product.

Authors:  Miklos Szabo; Daniel Sarkozy; Marton Szigeti; Robert Farsang; Zsofia Kardos; Adam Kozma; Eszter Csanky; Doo Soo Chung; Zoltan Szekanecz; Andras Guttman
Journal:  Front Bioeng Biotechnol       Date:  2022-03-08

2.  Affinity capillary electrophoresis - mass spectrometry permits direct binding assessment of IgG and FcγRIIa in a glycoform-resolved manner.

Authors:  Christoph Gstöttner; Alexander Knaupp; Gestur Vidarsson; Dietmar Reusch; Tilman Schlothauer; Manfred Wuhrer; Elena Domínguez-Vega
Journal:  Front Immunol       Date:  2022-09-08       Impact factor: 8.786

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.